CD5 and cancer: Six of these—CD5, CTLA4, TIGIT, LAIR1, PDCD1, and TNFRSF14—encode proteins that have been identified as immune checkpoints, defined broadly as receptors on immune cells that are exploited by cancer cells to escape the immune response.24, 25, 26, 27